Operative hysteroscopy versus ultrasound-guided electric vacuum aspiration for removal of retained products of conception: A prospective cohort study
- PMID: 37701632
- PMCID: PMC10493502
- DOI: 10.1016/j.eurox.2023.100230
Operative hysteroscopy versus ultrasound-guided electric vacuum aspiration for removal of retained products of conception: A prospective cohort study
Abstract
Objectives: To compare intrauterine adhesion (IUA) formation after hysteroscopic removal (HR) of retained products of conception (RPOC) with IUA formation after ultrasound-guided electric vacuum aspiration (EVA) and externally validate the outcomes of an RCT.
Study design: This prospective cohort study was conducted from April 2015 until June 2022 in 2 Dutch teaching hospitals and one Belgian university hospital. Women opting for EVA underwent the procedure as soon as possible. In the HR group, the therapeutic hysteroscopy was performed at least eight weeks after the end of pregnancy. Postoperatively, an office second-look hysteroscopy was offered to all patients. Women were included if they had been diagnosed with RPOC ranging from 1 to 4 cm on ultrasound and did not want to participate in the RCT. EVA was performed using a Karman cannula. Operative hysteroscopy consisted either of hysteroscopic morcellation with the TruClear™ System or the Intrauterine BIGATTI Shaver or cold loop resection with a bipolar resectoscope.
Results: Of 178 included women, 124 were treated with HR and 28 with EVA. Outcomes of HR and EVA did not differ significantly in terms of complications (5.6 % vs 3.6 %; p = 1.00). Second-look hysteroscopy showed IUAs in 14 of 91 women (15.4 %) after HR and in 1 of 16 (6.3 %) after EVA (p = .461). Completeness of removal was significantly higher (90.1 %) after HR than after EVA (68.8 %) (p = .035). Additional operative hysteroscopy was required in 14.3 % of the HR group versus 37.5 % in the EVA group (p = .036).
Conclusion: In our cohort study, no significant differences in IUAs or complications were found. RPOC removal with HR was more often complete than removal with EVA, and additional therapeutic hysteroscopy was less frequently required after HR. These findings need to be correlated with those of RCTs.
Clinical trial registration: The study was registered in de Dutch Trial Register (NTR4923). Date of registration 23-11-2014. Date of first enrollment 01-01-2015. https://trialsearch.who.int/Trial2.aspx?TrialID=NTR4923.
Keywords: Dilation and Curettage; Hysteroscopy; Intrauterine adhesions; Placental remnants; Retained products of conception.
© 2023 The Authors.
Conflict of interest statement
None.
Figures
Similar articles
-
Hysteroscopic morcellation vs. curettage for removal of retained products of conception: a multicenter randomized controlled trial.Fertil Steril. 2023 Dec;120(6):1243-1251. doi: 10.1016/j.fertnstert.2023.08.956. Epub 2023 Aug 30. Fertil Steril. 2023. PMID: 37657600 Clinical Trial.
-
Intrauterine adhesion in ultrasound-guided manual vacuum aspiration (USG-MVA) versus electric vacuum aspiration (EVA): a randomised controlled trial.BMC Pregnancy Childbirth. 2024 Feb 14;24(1):135. doi: 10.1186/s12884-024-06328-y. BMC Pregnancy Childbirth. 2024. PMID: 38355420 Free PMC article. Clinical Trial.
-
Operative hysteroscopy with the Bigatti shaver (IBS ®) for the removal of placental remnants.Facts Views Vis Obgyn. 2018 Sep;10(3):153-159. Facts Views Vis Obgyn. 2018. PMID: 31191850 Free PMC article.
-
Hysteroscopic management of retained products of conception: meta-analysis and literature review.Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:19-22. doi: 10.1016/j.ejogrb.2013.11.020. Epub 2013 Dec 1. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24332096 Review.
-
Hysteroscopic management of retained products of conception: A systematic review.Aust N Z J Obstet Gynaecol. 2022 Feb;62(1):22-32. doi: 10.1111/ajo.13455. Epub 2021 Nov 9. Aust N Z J Obstet Gynaecol. 2022. PMID: 34751942
References
-
- Golan A., Dishi M., Shalev A., Keidar R., Ginath S., Sagiv R. Operative hysteroscopy to remove retained products of conception: novel treatment of an old problem. J Minim Invasive Gynaecol. 2011;1:100–103. - PubMed
-
- Hooker A., Aydin H., Brölmann H.A.M., Huirne J.A.F. Long-term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertil Steril. 2016;105(1):156–164. - PubMed
-
- Kuzel D., Horak P., Hrazdirova L., Kubinova K., Sosna O., Mara M. “See and treat” hysteroscopy after missed abortion. Minim Invasive Ther Allied Technol. 2011;20(1):14–17. - PubMed
-
- Römer Post-abortion-hysteroscopy–a method for early diagnosis of congenital and acquired intrauterine causes of abortions. Eur J Obstet Gynecol Reprod Biol. 1994;57:171–173. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous